GoHealth Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In GoHealth, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - September 24, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in GoHealth, Inc. ("GoHealth" or the "Company") (NASDAQ: GOCO) of the November 20, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in GoHealth stock or options pursuant and/or traceable to the registration statement issued in connection with GoHealth's July 2020 initial public offering (the "IPO") and would like to discuss your legal rights, click here: www.faruqilaw.com/GOCO. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

A lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of all those who purchased GoHealth common stock pursuant and/or traceable to the registration statement issued in connection with GoHealth's July 2020 IPO. The case, Hudson v. GoHealth, Inc. et al., No. 1:20-cv-05593 was filed on September 21, 2020 and has been assigned to Judge Sharon Johnson Coleman.

As detailed below, the lawsuit focuses on whether the Registration Statement failed to disclose that, at the time of the IPO: (1) the Medicare insurance industry was undergoing a period of elevated churn, which had begun in the first half of 2020; (2) GoHealth suffered from a higher risk of customer churn as a result of its unique business model and limited carrier base; (3) GoHealth suffered from degradations in customer persistency and retention as a result of elevated industry churn, vulnerabilities that arose from the Company's concentrated carrier business model, and GoHealth's efforts to expand into new geographies, develop new carrier partnerships and worsening product mix; (4) GoHealth had entered into materially less favorable revenue sharing arrangements with its external sales agents; and (5) these adverse financial and operational trends were internally projected by GoHealth to continue and worsen following the IPO.

Shortly after the IPO, the price of GoHealth Class A common stock suffered significant price declines, and by September 15, 2020, GoHealth Class A common stock closed at just $12.53 per share - over 40% below the $21 per share price investors paid for the stock in the IPO less than two months previously.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding GoHealth's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/64617